Explore more publications!
Tech Press of Togo
Got News to Share?

Tech Press of Togo: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Press of Togo.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 13, 2026

G6 Hospitality to Convene Its Largest Franchise Conference in Cancún
Apr. 13, 2026

G6 Hospitality to Convene Its Largest Franchise Conference in Cancún

Indeterminate GlobeNewswire
Biomerica Reports Third Quarter Fiscal 2026 Financial Results
Apr. 13, 2026

Biomerica Reports Third Quarter Fiscal 2026 Financial Results

Indeterminate GlobeNewswire
Dash Social Brings Canva Into Its Platform, Connecting Design, Data, and Publishing for Social Teams
Apr. 13, 2026

Dash Social Brings Canva Into Its Platform, Connecting Design, Data, and Publishing for Social Teams

Indeterminate GlobeNewswire
AIM ImmunoTech Provides Routine Update on Annual Filings
Apr. 13, 2026

AIM ImmunoTech Provides Routine Update on Annual Filings

Indeterminate GlobeNewswire
CEA Industries Stapled Warrants to Begin Trading on Nasdaq Capital Market
Apr. 13, 2026

CEA Industries Stapled Warrants to Begin Trading on Nasdaq Capital Market

Indeterminate GlobeNewswire
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
Apr. 13, 2026

XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset

Indeterminate GlobeNewswire
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
Apr. 13, 2026

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock

Indeterminate GlobeNewswire
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
Apr. 13, 2026

ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors

Indeterminate GlobeNewswire
BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference
Apr. 13, 2026

BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
Datacentrex Reports Full Year 2025 Results; Achieves Positive Adjusted EBITDA in Transformational Year
Apr. 13, 2026

Datacentrex Reports Full Year 2025 Results; Achieves Positive Adjusted EBITDA in Transformational Year

Indeterminate GlobeNewswire
Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform
Apr. 13, 2026

Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform

Indeterminate GlobeNewswire
Les données intermédiaires de l'essai pivot testant cema-cel mettent en évidence la solidité de la plateforme CAR-T allogénique de Cellectis
Apr. 13, 2026

Les données intermédiaires de l'essai pivot testant cema-cel mettent en évidence la solidité de la plateforme CAR-T allogénique de Cellectis

Indeterminate GlobeNewswire
Rezolve Ai to Host Investor Call: The $700M+ Case for Combining with Commerce.com
Apr. 13, 2026

Rezolve Ai to Host Investor Call: The $700M+ Case for Combining with Commerce.com

Indeterminate GlobeNewswire
Varonis Announces Date of First Quarter 2026 Financial Results
Apr. 13, 2026

Varonis Announces Date of First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
Apr. 13, 2026

Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451

Indeterminate GlobeNewswire
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Apr. 13, 2026

BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Celldex to Present at Upcoming Investor Conference
Apr. 13, 2026

Celldex to Present at Upcoming Investor Conference

Indeterminate GlobeNewswire
Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes
Apr. 13, 2026

Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes

Indeterminate GlobeNewswire
Allogene Therapeutics Announces Proposed Public Offering of $175 Million of Common Stock
Apr. 13, 2026

Allogene Therapeutics Announces Proposed Public Offering of $175 Million of Common Stock

Indeterminate GlobeNewswire
Ventify AI Announces General Availability of People Intelligence Platform for High-Stakes Research and Discovery
Apr. 13, 2026

Ventify AI Announces General Availability of People Intelligence Platform for High-Stakes Research and Discovery

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions